Clinical Trial Update: Interferon-gamma or Aldesleukin and Vaccine Therapy in Treating Patients With Multiple Myeloma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating interferon-gamma or aldesleukin in combination with vaccine therapy for multiple myeloma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Plasma Cell Neoplasm

Drugs mentioned

• Aldesleukin (interleukin-2)
• Interferon-gamma (interferon gamma)

Snippet

Sponsor: Mayo Clinic | Conditions: Multiple Myeloma and Plasma Cell Neoplasm | Phase 2 | Status: COMPLETED